← Leaderboards
Amani A Fawzi
University Of Southern California
$9,595,823
Attributed
$16,073,014
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,073,014 · 7
By mechanism
R01$10,513,472 · 4
OT2$3,197,511 · 1
DP3$1,931,117 · 1
R21$430,914 · 1
Top collaborators
- Hao F Zhang6 shared
- Shuliang Jiao5 shared
- Roland Theodore Smith4 shared
- Stephen A. Burns2 shared
- Kathryn N Farrow2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Amir H Kashani$11,509,148
- Danny Jiong Jiong Wang$29,986,445
- John M Ringman$18,719,928
- Laurie D Deleve$11,554,929
- Grace Marie Richter$983,917
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaBlindnessBlood VesselsResearch PersonnelBlood FlowBlood CapillariesImageDiabetic RetinopathyAdultDiabetes MellitusOpticsTechnologyAnatomyRetinal DiseasesOxygenFunctional DisorderPathway InteractionsVascular DiseasesVisionAnimal ModelSuccessPreventPericytesEndothelial Cells
Grant awards (23)
Cellular-level Vascular Oculomics (CVO) for monitoring systemic vascular health$1,599,916
OT2 · FY2025 · OD · contact PI
Exploring the angiogenesis-to-fibrosis transition in ischemic retinopathies Renewal$679,986
R01 · FY2025 · EY · contact PI
Cellular-level Vascular Oculomics (CVO) for monitoring systemic vascular health$1,597,595
OT2 · FY2024 · OD · contact PI
Monitoring the hemodynamic response to therapy in diabetic retinopathy$465,498
R01 · FY2023 · EY · contact PI
Exploring the angiogenesis-to-fibrosis transition in ischemic retinopathies$383,915
R01 · FY2023 · EY · contact PI
Monitoring the hemodynamic response to therapy in diabetic retinopathy$446,878
R01 · FY2022 · EY · contact PI
Exploring the angiogenesis-to-fibrosis transition in ischemic retinopathies$372,397
R01 · FY2022 · EY · contact PI
Monitoring the hemodynamic response to therapy in diabetic retinopathy$482,525
R01 · FY2021 · EY · contact PI
Exploring the angiogenesis-to-fibrosis transition in ischemic retinopathies$375,709
R01 · FY2021 · EY · contact PI
Monitoring the hemodynamic response to therapy in diabetic retinopathy$504,307
R01 · FY2020 · EY · contact PI
Exploring the angiogenesis-to-fibrosis transition in ischemic retinopathies$395,000
R01 · FY2020 · EY · contact PI
Functional Retinal Imaging to Monitor Pharmaco-Therapies in Diabetic Retinopathy$1,931,117
DP3 · FY2015 · DK · contact PI
Multimodal Retinal Functional Imaging for Diabetic Retinopathy$542,822
R01 · FY2015 · EY
Manipulating cGMP Pathway to Impact Vascular Development in Neonatal BPD and ROP$229,568
R21 · FY2015 · HD · contact PI
Hyperspectral Imaging of the Normal and Age-related Macular Degeneration Fundus$850,573
R01 · FY2014 · EY
Multimodal Retinal Functional Imaging for Diabetic Retinopathy$547,068
R01 · FY2014 · EY
Manipulating cGMP Pathway to Impact Vascular Development in Neonatal BPD and ROP$201,346
R21 · FY2014 · HD · contact PI
Hyperspectral Imaging of the Normal and Age-related Macular Degeneration Fundus$824,707
R01 · FY2013 · EY
Multimodal Retinal Functional Imaging for Diabetic Retinopathy$576,574
R01 · FY2013 · EY
Hyperspectral Imaging of the Normal and Age-related Macular Degeneration Fundus$785,074
R01 · FY2012 · EY
Multimodal Retinal Functional Imaging for Diabetic Retinopathy$631,673
R01 · FY2012 · EY
Hyperspectral Imaging of the Normal and Age-related Macular Degeneration Fundus$984,154
R01 · FY2011 · EY
Multimodal Retinal Functional Imaging for Diabetic Retinopathy$664,612
R01 · FY2011 · EY